Actively Recruiting
Evaluation of Different Suture Materials and Closure Techniques in Lower Extremity Arthroplasty Effects on Wound Healing, Functional Outcomes, and Complications
Led by Bahattin Kemah · Updated on 2026-03-02
90
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial investigates the effects of different suture materials and wound closure techniques on wound healing, functional recovery, and postoperative complications in adults undergoing total hip or knee arthroplasty for osteoarthritis or revision surgery. The study aims to identify the most effective wound closure method to reduce issues such as prolonged drainage, wound opening, infection, and local inflammation. At least 90 patients will take part, with all surgeries performed by the same surgical team using standardized procedures to ensure consistency. Participants will be randomly assigned to one of two groups. One group will receive wound closure using barbed suture material with a continuous technique, while the other group will have conventional suture material applied with a standard interrupted closure method. Both approaches will be applied following primary or aseptic revision total hip or knee arthroplasty. The study will monitor effects during and after surgery to compare these two wound closure strategies. Patients will be followed for 90 days after surgery. Researchers will collect data on wound complications such as drainage duration, infections, wound reopening, and signs of inflammation. They will also record operative time, blood loss during surgery, cosmetic results, and functional scores of the hip or knee before surgery and three months afterward. All data will be analyzed to determine which closure method yields better healing and fewer complications, helping guide future surgical care.
CONDITIONS
Brief Title
Wound Closure Materials and Techniques in Hip and Knee Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 30 years or older
- Patients undergoing primary total hip arthroplasty or total knee arthroplasty
- Patients undergoing aseptic revision total hip or knee arthroplasty
- Surgery performed by the same surgical team
- Ability to provide informed consent
You will not qualify if you...
- Age less than 30 years
- Patients receiving immunosuppressive therapy
- Patients with complicated diabetes mellitus
- Chronic venous insufficiency
- Peripheral arterial disease
- Arthroplasty performed due to malignancy
- Active or previous surgical site infection
Research Team
B
Bahattin Kemah, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here